A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

Published 2012 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
Authors
Keywords
-
Journal
BLOOD
Volume 120, Issue 22, Pages 4317-4323
Publisher
American Society of Hematology
Online
2012-09-23
DOI
10.1182/blood-2012-06-437558
References
View 7 related references

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.